The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACUTUS MEDICAL INC | COM | 005111109 | 8,222 | 614,990 | SH | SOLE | 614,990 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 8,019 | 1,670,600 | SH | SOLE | 1,670,600 | 0 | 0 | ||
AERPIO PHARMACEUTICALS INC | COM | 00810B105 | 1,290 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 1,659 | 156,500 | SH | SOLE | 156,500 | 0 | 0 | ||
APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 5,209 | 871,800 | SH | SOLE | 871,800 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPONSORED ADS | 05280R100 | 12,107 | 2,112,918 | SH | SOLE | 2,112,918 | 0 | 0 | ||
AVEO BIOSCIENCES INC | COM NEW | 053588307 | 6,112 | 835,000 | SH | SOLE | 835,000 | 0 | 0 | ||
AYALA PHARMECEUTICALS INC | COM | 05465V108 | 1,184 | 108,551 | SH | SOLE | 108,551 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICAL HLDG | COM | G11196105 | 1,709 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADS | 09071M205 | 47 | 16,667 | SH | SOLE | 16,667 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 35,960 | 583,767 | SH | SOLE | 583,767 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 6,300 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
CARDIFF ONCOLOGY INC | COM | 14147L108 | 5,334 | 576,000 | SH | SOLE | 576,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 20,291 | 985,000 | SH | SOLE | 985,000 | 0 | 0 | ||
CERECOR INC | COM | 15671L109 | 7,852 | 2,600,000 | SH | SOLE | 2,600,000 | 0 | 0 | ||
CHECKPOINT THERAPEUTICS INC | COM | 162828107 | 9,188 | 2,925,963 | SH | SOLE | 2,925,963 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 43,284 | 4,490,000 | SH | SOLE | 4,490,000 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 32,046 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
CONTRAFECT CORP | COM NEW | 212326300 | 1,171 | 244,000 | SH | SOLE | 244,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 2,873 | 188,000 | SH | SOLE | 188,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 13,491 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 9,954 | 222,000 | SH | SOLE | 222,000 | 0 | 0 | ||
EDAP TMS SA | SPONSORED ADR | 268311107 | 2,867 | 341,300 | SH | SOLE | 341,300 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 8,252 | 284,050 | SH | SOLE | 284,050 | 0 | 0 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 29,573 | 4,040,000 | SH | SOLE | 4,040,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 5,102 | 147,000 | SH | SOLE | 147,000 | 0 | 0 | ||
FORTRESS BIOTECH INC | COM | 34960Q109 | 13,679 | 3,875,000 | SH | SOLE | 3,875,000 | 0 | 0 | ||
GEMINI THERAPEUTICS INC | COM | 36870G105 | 10,982 | 810,500 | SH | SOLE | 810,500 | 0 | 0 | ||
HARROW HEALTH INC | COM | 415858109 | 20,692 | 3,065,416 | SH | SOLE | 3,065,416 | 0 | 0 | ||
HIGHCAPE CAPITAL ACQUISITION CORP | COM CL A | 42984L105 | 2,876 | 241,300 | SH | SOLE | 241,300 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 7,491 | 467,000 | SH | SOLE | 467,000 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 9,694 | 157,500 | SH | SOLE | 157,500 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 4,239 | 711,200 | SH | SOLE | 711,200 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 5,940 | 320,926 | SH | SOLE | 320,926 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM | 52187K101 | 737 | 388,100 | SH | SOLE | 388,100 | 0 | 0 | ||
LUMOS PHARMA INC | COM | 55028X109 | 4,410 | 376,900 | SH | SOLE | 376,900 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 21,218 | 666,200 | SH | SOLE | 666,200 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 1,047 | 88,400 | SH | SOLE | 88,400 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 5,337 | 1,556,000 | SH | SOLE | 1,556,000 | 0 | 0 | ||
MYOVANT SCIENCES LTD | COM | G637AM102 | 5,141 | 249,800 | SH | SOLE | 249,800 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 15,080 | 1,225,000 | SH | SOLE | 1,225,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 106,337 | 6,480,000 | SH | SOLE | 6,480,000 | 0 | 0 | ||
OPTINOSE INC | COM | 68404V100 | 3,048 | 826,000 | SH | SOLE | 826,000 | 0 | 0 | ||
PROQR THERAPEUTICS NV | SHS EURO | N71542109 | 8,613 | 1,303,000 | SH | SOLE | 1,303,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 7,692 | 297,000 | SH | SOLE | 297,000 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 40,270 | 2,558,472 | SH | SOLE | 2,558,472 | 0 | 0 | ||
SANARA MEDTECH INC | COM | 79957L100 | 7,009 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
SERES THERAPEUTICS | COM | 81750R102 | 9,804 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 2,604 | 151,139 | SH | SOLE | 151,139 | 0 | 0 | ||
SIO GENE THERAPIES INC | COM | 829399104 | 5,220 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 16,978 | 2,526,500 | SH | SOLE | 2,526,500 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 7,783 | 341,950 | SH | SOLE | 341,950 | 0 | 0 | ||
TELA BIO INC | COM | 872381108 | 5,439 | 365,000 | SH | SOLE | 365,000 | 0 | 0 | ||
TRACON PHARMACEUTICALS INC | COM NEW | 89237H209 | 20,726 | 2,518,371 | SH | SOLE | 2,518,371 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 7,067 | 357,800 | SH | SOLE | 357,800 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 5,743 | 2,325,000 | SH | SOLE | 2,325,000 | 0 | 0 | ||
VIRACTA THERAPEUTICS INC | COM | 92765F108 | 958 | 103,600 | SH | SOLE | 103,600 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 17,854 | 437,500 | SH | SOLE | 437,500 | 0 | 0 |